Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with Philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia: a Canadian consensus.
about
The evolving role of chemotherapy and hematopoietic cell transplants in Ph-positive acute lymphoblastic leukemia in adults.New Treatment Strategies for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for High-Risk Acute Lymphoblastic Leukemia.The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology.Clinical significance of quantitative monitoring and mutational analysis of BCR-ABL1 transcript in Philadelphia chromosome positive B lymphoblastic leukemia.
P2860
Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with Philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia: a Canadian consensus.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Evidence-based guidelines for ...... eukemia: a Canadian consensus.
@en
type
label
Evidence-based guidelines for ...... eukemia: a Canadian consensus.
@en
prefLabel
Evidence-based guidelines for ...... eukemia: a Canadian consensus.
@en
P2093
P2860
P356
P1433
P1476
Evidence-based guidelines for ...... eukemia: a Canadian consensus.
@en
P2093
A Christofides
S Lachance
Y Abou Mourad
P2860
P304
P356
10.3747/CO.21.1834
P50
P577
2014-04-01T00:00:00Z